Almac Completes Its Expansion Plan to Pharma Services Facilities
Almac’s Pharma Services
business unit has announced the completion of a $13.75 million expansion to the company’s existing facilities at the Group’s headquarters in Craigavon, Northern Ireland.
The completion of a three story extension to the existing commercial manufacture facility in June 2009 expanded Pharma Services’ laboratory and office areas by 30,000 ft2. The new laboratories aim to enhance the existing analytical and microbiological drug product support services.
Remodelling of the now 120,000 ft2 commercial manufacture facility was completed in March 2010. Remodeling included expansion in microbiological and sterility test areas, new yellow light labs, and office and meeting room expansion. Method development, validation, and transfer supporting multiple client projects, are offered over a wide range of technologies from our expanded facility.
Graeme McBurney, President & M.D of Almac Pharma Services commented: “Increased client demand for our integrated services has resulted in the strategic decision to make this investment and expansion, both in terms of space and the additional team members we are recruiting. I look forward to working with the current and new members of our team.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
